EP1954827A1 - Rapid parallel nucleic acid analysis - Google Patents
Rapid parallel nucleic acid analysisInfo
- Publication number
- EP1954827A1 EP1954827A1 EP06826449A EP06826449A EP1954827A1 EP 1954827 A1 EP1954827 A1 EP 1954827A1 EP 06826449 A EP06826449 A EP 06826449A EP 06826449 A EP06826449 A EP 06826449A EP 1954827 A1 EP1954827 A1 EP 1954827A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- nucleotide
- nucleic acid
- template
- dna polymerase
- templates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
Definitions
- the present invention relates generally to methods of high throughput, parallel sequencing of polynucleotides. More specifically, the invention relates to sequencing using an improved pyrosequencing technique that enables detection of each base of a polynucleotide template.
- DNA polymerases are enzymes which are useful in many recombinant DNA techniques, such as nucleic acid amplification by the polymerase chain reaction (“PCR"), self-sustained sequence replication (“3 SR”), and DNA sequencing. Thermostable DNA polymerases are particularly useful. Because heat does not destroy the polymerase activity, there is no need to add additional polymerase after every denaturation step.
- PCR polymerase chain reaction
- 3 SR self-sustained sequence replication
- DNA sequencing DNA sequencing.
- Thermostable DNA polymerases are particularly useful. Because heat does not destroy the polymerase activity, there is no need to add additional polymerase after every denaturation step.
- the DNA polymerase-DNA complexes formed are known to undergo a rate-limiting, conformational transition from an 'open' to 'closed' state, upon binding of the 'correct' dNTP or ddNTP at the active site.
- Mg 2+ or other metal ion
- Mg 2+ mediates a rapid chemical step involving nucleophilic displacement of pyrophosphate by the 3 ' hydroxyl of the primer terminus.
- the enzyme returns to the 'open' state upon the release of pyrophosphate (PPi) and translocation initiates the next round of reaction.
- ternary complex Enzyme-DNA-dNTP (or ddNTP) can form in the absence OfMg 2+ (or other metal ions)
- Mg 2+ (or other metal ion)-deficient conditions tend to lead to non-covalent (physical) sequestration of first 'correct' dNTP in a tight ternary complex (Ducce et ⁇ l. (15 February 1999) Structure Fold. Des., 7(2):R31-5).
- PPi reveals the identity of the next correct base.
- a sequence from a template is obtained or confirmed. Additional nucleotides of the sequence are obtained by cycling of the polymerase reaction, in the presence of a single nucleotide at a time.
- Pyrosequencing does not require the separation or sizing of the reaction products by such methods as electrophoresis. It is capable of being performed in a massively parallel fashion. Pyrosequencing has been used successfully for a number of applications, including in clinical microbiology. A 96 well plate format is the most widely used format (see Biotage AB website).
- ATP-sulfurylase uses two enzymes, ATP-sulfurylase and luciferase, to produce a light emission.
- ATP- sulfurylase generates ATP at the presence of PPi and adenosine-5'-phospho sulfate.
- Luciferase uses the ATP to convert luciferin to oxyluciferin, emitting a photon. Nyren et al., 151 Analytical Biochemistry 504 (1985).
- Luciferase is not absolutely specific for ATP, it can also work with dATP, and to a lesser extent may catalyze reaction with other nucleoside triphosphates as well.
- This invention makes use of the above observation by use of the closed complex to freeze the polymerase activity during DNA synthesis, trapping the nucleotide which is complementary to the next template nucleotide, to allow the determination of the identity of the next correct nucleotide. It can then be identified either in place, as part of the complex, or as the pyrophosphate or dye-labeled polyphosphate is released from the complex when the reaction cycle is completed by the addition of divalent metal ion. hi this way, sequential nucleotides of a DNA can be identified, effectively determining the DNA sequence. With sufficiently sensitive detection methods, this method can be applied both to single molecules of template nucleic acid or to collections of identical (or nearly identical) sequence such as PCR products or clones.
- multiple templates can be sequenced in parallel, particularly if they are effectively immobilized on a solid support such as plates or beads.
- This invention combines pyrosequencing with closed complex formation to enable accurate, parallel sequencing of nucleic acid templates. It eliminates non-specificity of the pyrosequencing reaction, provides accurate sequence for each base of the polynucleotide sequence, and the nucleotides do not need to be labeled. When combined with microbeads and the picoliter-sized reaction well technology, it provides ultra-high throughput, non- ambiguous nucleic acid sequence at a short period of time.
- Figure 3 depicts the reaction and detection scheme for sequencing by phosphate labeled nucleotides pausing at the closed complex stage. Complex is only partially stable for the full time scale of washing and detection. Sequence obtained will not distinguish multiples of a base (A, AA, AAA etc.) in the sequence.
- Figure 4 depicts the reaction scheme for parallel sequencing by phosphate labeled nucleotides pausing at the closed complex stage of arrays of targets. Complex is only partially stable for the full time scale of washing and detection. Sequence obtained will not distinguish multiples of a base (A, AA, AAA etc.) in the sequence.
- Figure 5 presents evidence of the formation of the stable closed complex using fiuorescently labeled nucleotides. It clearly demonstrates that the complex can be detected as described herein.
- Figure 6 demonstrates how SDS destroys the closed complex.
- Figure 7 demonstrates polymerase titration of the closed complex.
- Figure 8 depicts the reaction and detection scheme for sequencing with primed templates attached to individual beads.
- nucleoside is a compound including a purine, deazapurine, pyrimidine or modified base linked to a sugar or a sugar substitute, such as a carbocyclic or acyclic moiety, at the 1 ' position or equivalent position and includes 2'-deoxy and 2'-hydroxyl, and 2', 3'-dideoxy forms as well as other substitutions.
- nucleotide refers to a phosphate ester of a nucleoside, wherein the esterification site typically corresponds to the hydroxyl group attached to the C-5 position of the pentose sugar.
- nucleotides that may form closed complexes with polymerases, templates and primers
- the term specifically refers to triphosphates, tetraphosphates or esters of even longer polyphosphates which optionally may be labeled on the terminal phosphate with a colored, fluorescent, chemiluminescent, or other detectable moiety.
- oligonucleotide includes linear oligomers of nucleotides or derivatives thereof, including deoxyribonucleosides, ribonucleosides, and the like. Throughout the specification, whenever an oligonucleotide is represented by a sequence of letters, the nucleotides are in the 5' ⁇ 3' order from left to right where A denotes deoxyadenosine, C denotes deoxycytidine, G denotes deoxyguanosine, and T denotes thymidine, unless noted otherwise.
- primer refers to a linear oligonucleotide that anneals in a specific way to a unique nucleic acid sequence and allows for amplification of that unique sequence.
- target nucleic acid sequence refers to a nucleic acid whose sequence identity, or ordering or location of nucleosides is determined by one or more of the methods of the present invention.
- emulsion PCR is also referred to as "ePCR”.
- emulsion PCR a water-in-oil emulsion permits millions of non-interaction amplifications within a milliliter-scale volume (Tawf ⁇ k and Griffiths, Nature Biotechnology 16, 652, July 1998; Ghadessy et al., PNAS 98, 4552, April 10, 2001 ; Nakano et al., Journal of Biotechnology 102, 117, April 24, 2003).
- Amplification products of individual compartments are captured via inclusion of beads bearing one of the PCR primers (Dressman et al., PNAS 100, 8817, July 22, 2003; Margulies et al., Nature advance online publication; published online 31 July 2005, doi: 10.1038/nature03959). Any single bead bears thousands of single-stranded copies of the same PCR product, whereas different beads bear the products of different compartmentalized PCR reactions.
- the present invention relates to methods of characterizing a polynucleotide in a sample wherein a convenient assay is used for monitoring RNA or DNA synthesis via nucleic acid polymerase activity.
- Nucleic acid polymerizing enzymes synthesize nucleic acid molecules via transfer of a nucleoside monophosphate from a nucleoside triphosphate (NTP) or deoxynucleoside triphosphate (dNTP) to the 3' hydroxyl of a growing oligonucleotide chain. This reaction also releases inorganic pyrophosphate.
- the polymerase is a DNA polymerase, such as DNA polymerase I, II, or III or DNA polymerase ⁇ , ⁇ , ⁇ , or terminal deoxynucleotidyl transferase or telomerase.
- the methods provided by this invention utilize a nucleoside polyphosphate, such as a deoxynucleoside polyphosphate, dideoxynucleoside polyphosphate, carbocyclic nucleoside polyphosphate, or acylic nucleoside polyphosphate analogue with a colorimetric dye, or a fluorescent label.
- the base in these nucleoside polyphosphate is selected from the group consisting of uracil, thymine, cytosine, 5- methylcytosine, guanine, 7-deazaguanine, hypoxanthine, 7-deazahypoxanthine, adenine, 7-deazaadenine, 2,6-diaminopurine and analogs thereof.
- the methods of the current invention can also be adapted to perform massively parallel reactions, to sequence multiple templates at the same time.
- the ternary complex of polymerase-template-nucleotide can be immobilized on beads within confined locations of a carrier (e.g. capillary), or they can be immobilized on the inner surface of a microchannel, or on a surface of a microscope slide or the like.
- the surface of a microscope slide can be a planar surface, or a coated surface.
- the surface may comprise a plurality of microfeatures arranged in spatially discrete regions to produce a texture on the surface, wherein the textured surface provides an increase in surface area as compared to a non-textured surface.
- the species (the primer, the nucleic acid template, the nucleic acid polymerization enzyme, or the primer-template complex, or the ternary complex) immobilized can form an ordered pattern on the support surface.
- the species can also be immobilized randomly on the surface. However, each different species is located at a discrete location so that signal from any dye bound to one complex (or homogeneous population of complexes) is readily distinguishable from signal of another, adjacently immobilized complex.
- the steps include: a) immobilizing a plurality of primers or nucleic acid templates on a support structure, wherein each primer or template contains a unique sequence and wherein each primer (or multiple copies of the same primer) or template is localized to an identifiable, discrete location on the support structure; b) initiating a plurality of nucleic acid polymerization reactions on the support structure, by forming a reaction mixture, the reaction mixture including the plurality of primers, the plurality of nucleic acid templates, a nucleic acid polymerizing enzyme, and at least one terminal-phosphate-labeled nucleotides each containing a distinct label, wherein each of the terminal-phosphate-labeled nucleotides contains a base complementary to each of the
- each of the template (or primer) used for the nucleic acid polymerase reaction is a single molecule or a homogeneous population of molecules.
- steps (a) through (e) above the following steps are performed: f) adding a divalent cation to complete the polymerization reactions; g) removing the divalent cation and other end products from the polymerization reactions; and h) repeating steps (a) through (g) for the characterization of each additional nucleotide of the plurality of nucleic acid templates.
- Figure 1 depicts the multiplexing embodiment of the invention.
- the steps include: (a) initiating a nucleic acid polymerization reaction on a support, by forming a reaction mixture, the reaction mixture including a nucleic acid template, a primer, a nucleic acid polymerizing enzyme, and at least one terminal-phosphate-labeled nucleotides each containing a distinct label, wherein a component of the reaction mixture or a first complex of two or more of the components, is immobilized on the support, and the component or components are selected from the group consisting of the nucleic acid template, the primer, and the nucleic acid polymerizing enzyme, and wherein each of the at least one terminal-phosphate-labeled nucleotides contains a base complementary to the four naturally occurring bases; (b) progressing the nucleic acid polymerization reaction by incubating the reaction mixture to form a second complex comprising the nucleic acid template, primer, nucleic acid polymerizing enzyme, and
- the present invention further provides methods of sequencing a target sequence using the steps described above in a continuous flow or a stop-flow system, where the immobilized material is held in place by any one of the means known in the art and different reagents and buffers are pumped in to the system at one end and exit the system at the other end. Reagents and buffers may flow continuously or may be held in place for certain time to allow for the polymerization reaction to proceed.
- An illustration of the process is presented in Figure 2. As shown in Figure 2, beads within a microchannel provide support surface for the immobilization of the reaction complexes. As the buffers and reagents move along through the system, the dye released from the polymerase reaction moves directionally toward the exiting end of the microchannel.
- the detection technique involves observing microscopic "flashes” of fluorescence at the site of the complex which would indicate the temporary (duration of seconds), binding of the next correct nucleotide (labeled), (resulting in a colored "glittering" of the DNA-DNA polymerase complex). Since the "closed complex” that is only formed with the next correct nucleotide, has at least 10-times longer lifetime than an open complex containing the incorrect next nucleotide, its fluorescence will dominate the observed signal at the site of the complex. This should be readily distinguishable from fluorescence of free nucleotide which will only remain at the site of the complex a very brief time, particularly when present at low concentration.
- the steps include: a) initiating a nucleic acid polymerization reaction on a support, by forming a reaction mixture, the reaction mixture including a nucleic acid template, a primer, a nucleic acid polymerizing enzyme, and at least one nucleotides each containing a distinct label, wherein a component of the reaction mixture or a first complex of two or more of the components, is immobilized on the support, and the component or components are selected from the group consisting of the nucleic acid template, the primer, and the nucleic acid polymerizing enzyme, and wherein one of the at least one labeled nucleotides contains a base complementary to the template base at the site of polymerization; b) incubating the reaction mixture to form a second complex comprising the nucleic acid template, primer, nucleic acid polymerizing enzyme, and one of the at least one labeled nucle
- each of the template (or primer) used for the nucleic acid polymerase reaction is a single molecule or a homogeneous population of molecules.
- the drawback to this method would be that runs of the same bases could not be fully sequenced.
- a sequence of GGGTTTCCTCTC SEQ ID NO: 1 would be read as GTCTCTC (SEQ ID NO: 2), but this information is useful in many situations. While this method only provides sequence information of the first base, cycling of a similar method can provide sequence information for multiple bases of each template.
- Another method that could be used in a multiplexed format will also allow sequencing of tens of thousands of templates simultaneously in a very short time or sequencing long regions of DNA. This method could be used to obtain sequence of multiple bases from the same template, with the same limitation. Runs of the same bases could not be easily detected (e.g. GGGTTTCCTCTC (SEQ ID NO: I)) would be read as GTCTCTC (SEQ ID NO: 2).
- the steps include: a) immobilizing a plurality of primers on a support structure, wherein each primer contains a unique sequence and wherein each primer is localized to an identifiable, discrete location on the support structure; b) initiating a plurality of nucleic acid polymerization reactions on the support structure, by forming a reaction mixture, the reaction mixture including the plurality of immobilized primers, a plurality of nucleic acid templates, a nucleic acid polymerizing enzyme, and one labeled nucleotides; c) incubating the reaction mixture to form a plurality of second complexes, each comprising one of the plurality of immobilized primers, one of the plurality of nucleic acid templates, the nucleic acid polymerizing enzyme, and the labeled nucleotide, wherein the labeled nucleotide contains a base complementary to the template base at the site of polymerization
- the data (dye label information) obtained from this method are processed in a computer system with an appropriate algorithm.
- the data are converted to sequence information of each of the four nucleotides, either instantaneously as the data is generated, or at the end of the experimental reactions.
- the sequences are next assembled for each of the plurality of nucleic acid templates. It is noted that the order of addition of labeled nucleotides can occur in a preset cycle, but it is not essential.
- the following example illustrates the process for determining the sequence of two template nucleic acid molecules using the above method. Assuming the sequences to be analyzed are (a) GGGTTTCCTCTC (SEQ ID NO: 1) and (b)
- step (j) a nucleotide complementary to G is added.
- a signal is detected from the location where the next nucleotide base on the template is a G (in this case SEQ ID NO: 1).
- a signal is not detected from the location where the next nucleotide base on the template is not a G (in this case SEQ ID NO: 3, which contains a next C).
- the information is recorded to a data storage media.
- a nucleotide complementary to C is added.
- the method can still be used to sequence single molecules.
- the detection technique involves observing microscopic "flashes" at the site of the complex which would indicate the temporary (duration of seconds to minutes), binding of the next correct nucleotide (labeled). While terminal phosphate labeled dNTPs or ddNTPs could be used, so could base labeled ddNTPs.
- the only drawback to this technique would be that runs of the same bases could not be fully sequenced. For example, a sequence of GGGTTTCCTCTC (SEQ ID NO: 1) would be read as GTCTCTC (SEQ ID NO: 2), but this information is useful.
- the steps include: (a) initiating a nucleic acid polymerization reaction on a support, by forming a reaction mixture, the reaction mixture including a nucleic acid template, a primer, a nucleic acid polymerizing enzyme, and at least one nucleotides each containing a distinct label, wherein a component of the reaction mixture or a first complex of two or more of the components, is immobilized on the support, and the component or components are selected from the group consisting of the nucleic acid template, primer, and nucleic acid polymerizing enzyme, and wherein one of the at least one labeled nucleotides contains a base complementary to the template base at the site of polymerization; (b) incubating the reaction mixture to form a second complex comprising the nucleic acid template, primer, nucleic acid polymerizing enzyme, and one of the at least one labeled nucleot
- the template used for the nucleic acid polymerase reaction is a single molecule, or a homogeneous population of molecules.
- steps (a) through (e) above the following steps are performed: (f) adding, to the reaction mixture, a nucleic acid polymerizing enzyme, a divalent cation, and an un-labeled nucleotide containing identified base sequence; (g) completing the polymerization reaction by incubating the reaction mixture for a period of time; (h) removing the divalent cation and other end products from the polymerization reaction; and (i) repeating steps (a) through (h) for each additional nucleotide to be sequenced. If the labeled nucleotides are base labeled, it is preferred that an additional wash step is performed before step (f) to get rid of the template-primer-polymerase complex captured labeled nucleotides.
- Figure 3 depicts the reaction and detection scheme for sequencing by phosphate labeled nucleotides pausing at the closed complex stage as detailed above.
- the only drawback of this method is that runs of the same bases could not be fully sequenced.
- GGGTTTCCTCTC SEQ ID NO: 1
- GTCTCTC SEQ ID NO: 2
- the steps include: (a) immobilizing a plurality of primers on a support structure, wherein each primer contains a unique sequence and wherein each primer is localized to an identifiable, discrete location on the support structure; (b) initiating a plurality of nucleic acid polymerization reactions on the support structure, by forming a reaction mixture, including the plurality of immobilized primers, a plurality of nucleic acid templates, a nucleic acid polymerizing enzyme, and at least one labeled nucleotides; (c) incubating the reaction mixture to form a plurality of second complexes, each comprising one of the plurality of immobilized primers, one of the plurality
- the DNA polymerase-DNA complex formed is known to undergo a rate-limiting, conformational transition from an 'open' to 'closed' state, after binding of the 'correct' dNTP or ddNTP at the active site.
- the ternary complexes Enzyme-DNA-dNTP (or ddNTP) form, but the dNTP or ddNTP is not added to the growing nucleic acid molecule. This leads to non- covalent (physical) sequestration of the next, 'correct' nucleotide in the ternary complex.
- the detection step is performed before the addition of the divalent cation. It is noted that because, in many cases, the nucleic acid molecules sequenced are concentrated at discrete locations, the concentration of sequestered labeled nucleotides is higher than the free floating nucleotides. If the detection system is site- specific and sensitive enough, and the free floating, labeled nucleotide is at a sufficiently low concentration, it is possible to detect the nucleotides in the closed complex without the removal of unbound nucleotides.
- the nucleotide may contain an enzyme activatable label on the terminal phosphate. After polymerization, the enzyme activatable label is present on the inorganic polyphosphate by-product. Cleavage of the polyphosphate by-product by phosphatase could generate a detectable label. If the labels are distinct for each nucleotide, all four nucleotides can be distinguished in the same reaction. If the labels are not distinct, each nucleotide is introduced separately, to distinguish the different nucleotides.
- Streptavidin-coated sepharose beads have been used to immobilize PCR amplified, biotinylated single stranded DNA.
- a 96 well plate format pyrosequencing platform is developed and commercialized by Biotage AB. Each well of a 96 well plate contains beads carrying a single type of single stranded template DNA. Using this platform, 96 reactions can be carried out at the same time. The combination of the 96-well format, with the closed complex formation, provides improved, accurate sequencing results not achievable by the conventional pyrosequencing technique.
- Nucleotide incorporation is detected, as an example, by the detection of photons generated from the Luciferase reaction following conversion of pyrophosphate product through a succession of enzymatic steps (Hyman US patent number 4,971,903). It is noted that the precision of detecting multiple nucleotide additions is limited by the efficiency and precision of the light-measurement system as well as the succession of enzymes needed to convert the pyrophosphate to the detected light output.
- Figure 10 depicts the reaction and detection scheme for sequencing by the new, stepwise method with pyrophosphate detection.
- Figure 1OA shows the reaction of an individual bead when one of four nucleotides is added to the reaction system.
- polymerase forms a stable, closed-complex with the nucleotide (e.g. dATP) that complements the next template nucleotide (e.g. T, partial template sequence shown: 5'-GCTTTTTCT-3' (SEQ ID NO: 6)). Excess nucleotide is washed away.
- nucleotide e.g. dATP
- T partial template sequence shown: 5'-GCTTTTTCT-3' (SEQ ID NO: 6)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/255,683 US7264934B2 (en) | 2004-06-10 | 2005-10-21 | Rapid parallel nucleic acid analysis |
PCT/US2006/041232 WO2007048033A1 (en) | 2005-10-21 | 2006-10-20 | Rapid parallel nucleic acid analysis |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1954827A1 true EP1954827A1 (en) | 2008-08-13 |
EP1954827A4 EP1954827A4 (en) | 2009-12-09 |
EP1954827B1 EP1954827B1 (en) | 2013-07-24 |
Family
ID=37962856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06826449.8A Active EP1954827B1 (en) | 2005-10-21 | 2006-10-20 | Rapid parallel nucleic acid analysis |
Country Status (4)
Country | Link |
---|---|
US (1) | US7264934B2 (en) |
EP (1) | EP1954827B1 (en) |
JP (1) | JP5160433B2 (en) |
WO (1) | WO2007048033A1 (en) |
Families Citing this family (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1597602A4 (en) * | 2003-02-05 | 2009-07-22 | Ge Healthcare Bio Sciences | SEQUEN AGE IN SOLID PHASE |
DE602005020011D1 (en) * | 2004-06-10 | 2010-04-29 | Ge Healthcare Bio Sciences | PROCESS FOR NUCLEIC ACID ANALYSIS |
US7264934B2 (en) * | 2004-06-10 | 2007-09-04 | Ge Healthcare Bio-Sciences Corp. | Rapid parallel nucleic acid analysis |
US8536661B1 (en) | 2004-06-25 | 2013-09-17 | University Of Hawaii | Biosensor chip sensor protection methods |
US7563574B2 (en) * | 2006-03-31 | 2009-07-21 | Pacific Biosciences Of California, Inc. | Methods, systems and compositions for monitoring enzyme activity and applications thereof |
US9114398B2 (en) | 2006-11-29 | 2015-08-25 | Canon U.S. Life Sciences, Inc. | Device and method for digital multiplex PCR assays |
US8349167B2 (en) | 2006-12-14 | 2013-01-08 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
US7948015B2 (en) | 2006-12-14 | 2011-05-24 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
US11339430B2 (en) | 2007-07-10 | 2022-05-24 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
US8262900B2 (en) | 2006-12-14 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
EP2657869A3 (en) | 2007-08-29 | 2015-06-03 | Applied Biosystems, LLC | Alternative nucleic acid sequencing methods |
US8652781B2 (en) | 2008-02-12 | 2014-02-18 | Pacific Biosciences Of California, Inc. | Cognate sampling kinetics |
WO2009145828A2 (en) * | 2008-03-31 | 2009-12-03 | Pacific Biosciences Of California, Inc. | Two slow-step polymerase enzyme systems and methods |
US8420366B2 (en) * | 2008-03-31 | 2013-04-16 | Pacific Biosciences Of California, Inc. | Generation of modified polymerases for improved accuracy in single molecule sequencing |
US8999676B2 (en) | 2008-03-31 | 2015-04-07 | Pacific Biosciences Of California, Inc. | Recombinant polymerases for improved single molecule sequencing |
AU2009251883B2 (en) * | 2008-03-31 | 2014-09-11 | Pacific Biosciences Of California, Inc. | Generation of modified polymerases for improved accuracy in single molecule sequencing |
CN102203282B (en) | 2008-06-25 | 2014-04-30 | 生命技术公司 | Methods and apparatus for measuring analytes using large scale FET arrays |
US20110229877A1 (en) | 2008-07-07 | 2011-09-22 | Oxford Nanopore Technologies Limited | Enzyme-pore constructs |
US20100227327A1 (en) * | 2008-08-08 | 2010-09-09 | Xiaoliang Sunney Xie | Methods and compositions for continuous single-molecule nucleic acid sequencing by synthesis with fluorogenic nucleotides |
US20100036110A1 (en) * | 2008-08-08 | 2010-02-11 | Xiaoliang Sunney Xie | Methods and compositions for continuous single-molecule nucleic acid sequencing by synthesis with fluorogenic nucleotides |
EP2326733A2 (en) * | 2008-09-05 | 2011-06-01 | Pacific Biosciences of California, Inc. | Engineering polymerases and reaction conditions for modified incorporation properties |
US20100301398A1 (en) | 2009-05-29 | 2010-12-02 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
US20100137143A1 (en) * | 2008-10-22 | 2010-06-03 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
WO2010111690A2 (en) | 2009-03-27 | 2010-09-30 | Life Technologies Corporation | Polymerase compositions and methods |
US20120261274A1 (en) | 2009-05-29 | 2012-10-18 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
US8776573B2 (en) | 2009-05-29 | 2014-07-15 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
US8574835B2 (en) | 2009-05-29 | 2013-11-05 | Life Technologies Corporation | Scaffolded nucleic acid polymer particles and methods of making and using |
US8673627B2 (en) | 2009-05-29 | 2014-03-18 | Life Technologies Corporation | Apparatus and methods for performing electrochemical reactions |
WO2010141390A2 (en) | 2009-06-05 | 2010-12-09 | Life Technologies Corporation | Nucleotide transient binding for sequencing methods |
JP5618556B2 (en) * | 2010-01-28 | 2014-11-05 | 株式会社日立ハイテクノロジーズ | Nucleic acid analyzer, nucleic acid analysis reaction device, and substrate for nucleic acid analysis reaction device |
TWI547688B (en) | 2010-06-30 | 2016-09-01 | 生命技術公司 | Ion-sensing charge-accumulation circuits and methods |
US20120001646A1 (en) | 2010-06-30 | 2012-01-05 | Life Technologies Corporation | Methods and apparatus for testing isfet arrays |
CN109449171A (en) | 2010-06-30 | 2019-03-08 | 生命科技公司 | For detecting and measuring the transistor circuit of chemical reaction and compound |
US11307166B2 (en) | 2010-07-01 | 2022-04-19 | Life Technologies Corporation | Column ADC |
JP5876044B2 (en) | 2010-07-03 | 2016-03-02 | ライフ テクノロジーズ コーポレーション | Chemically sensitive sensor with lightly doped drain |
US8986930B2 (en) | 2010-07-12 | 2015-03-24 | Pacific Biosciences Of California, Inc. | Sequencing reactions with alkali metal cations for pulse width control |
US9618475B2 (en) | 2010-09-15 | 2017-04-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
CN105911126B (en) | 2010-09-24 | 2018-12-18 | 生命科技公司 | Matched transistor pair circuit |
US9970984B2 (en) | 2011-12-01 | 2018-05-15 | Life Technologies Corporation | Method and apparatus for identifying defects in a chemical sensor array |
US8821798B2 (en) | 2012-01-19 | 2014-09-02 | Life Technologies Corporation | Titanium nitride as sensing layer for microwell structure |
US8747748B2 (en) | 2012-01-19 | 2014-06-10 | Life Technologies Corporation | Chemical sensor with conductive cup-shaped sensor surface |
WO2013166303A1 (en) | 2012-05-02 | 2013-11-07 | Ibis Biosciences, Inc. | Dna sequencing |
US10584377B2 (en) | 2012-05-02 | 2020-03-10 | Ibis Biosciences, Inc. | DNA sequencing |
EP3789502A1 (en) | 2012-05-02 | 2021-03-10 | Ibis Biosciences, Inc. | Dna sequencing |
EP2662692A1 (en) | 2012-05-11 | 2013-11-13 | Alacris Theranostics GmbH | Electrochemical detection of polymerase reactions by specific metal-phosphate complex formation |
US8786331B2 (en) | 2012-05-29 | 2014-07-22 | Life Technologies Corporation | System for reducing noise in a chemical sensor array |
WO2013185137A1 (en) | 2012-06-08 | 2013-12-12 | Pacific Biosciences Of California, Inc. | Modified base detection with nanopore sequencing |
US9725768B2 (en) | 2012-08-31 | 2017-08-08 | Biovest International, Inc. | Methods for producing high-fidelity autologous idiotype vaccines |
US9399766B2 (en) | 2012-10-01 | 2016-07-26 | Pacific Biosciences Of California, Inc. | Recombinant polymerases for incorporation of protein shield nucleotide analogs |
US9080968B2 (en) | 2013-01-04 | 2015-07-14 | Life Technologies Corporation | Methods and systems for point of use removal of sacrificial material |
US9841398B2 (en) | 2013-01-08 | 2017-12-12 | Life Technologies Corporation | Methods for manufacturing well structures for low-noise chemical sensors |
US8962366B2 (en) | 2013-01-28 | 2015-02-24 | Life Technologies Corporation | Self-aligned well structures for low-noise chemical sensors |
US8841217B1 (en) | 2013-03-13 | 2014-09-23 | Life Technologies Corporation | Chemical sensor with protruded sensor surface |
US8963216B2 (en) | 2013-03-13 | 2015-02-24 | Life Technologies Corporation | Chemical sensor with sidewall spacer sensor surface |
US20140264471A1 (en) | 2013-03-15 | 2014-09-18 | Life Technologies Corporation | Chemical device with thin conductive element |
US9835585B2 (en) | 2013-03-15 | 2017-12-05 | Life Technologies Corporation | Chemical sensor with protruded sensor surface |
EP2972280B1 (en) | 2013-03-15 | 2021-09-29 | Life Technologies Corporation | Chemical sensor with consistent sensor surface areas |
US9116117B2 (en) | 2013-03-15 | 2015-08-25 | Life Technologies Corporation | Chemical sensor with sidewall sensor surface |
JP6581074B2 (en) | 2013-03-15 | 2019-09-25 | ライフ テクノロジーズ コーポレーション | Chemical sensor with consistent sensor surface area |
US20140336063A1 (en) | 2013-05-09 | 2014-11-13 | Life Technologies Corporation | Windowed Sequencing |
US10458942B2 (en) | 2013-06-10 | 2019-10-29 | Life Technologies Corporation | Chemical sensor array having multiple sensors per well |
US10605767B2 (en) | 2014-12-18 | 2020-03-31 | Life Technologies Corporation | High data rate integrated circuit with transmitter configuration |
US10077472B2 (en) | 2014-12-18 | 2018-09-18 | Life Technologies Corporation | High data rate integrated circuit with power management |
CN111505087A (en) | 2014-12-18 | 2020-08-07 | 生命科技公司 | Method and apparatus for measuring analytes using large scale FET arrays |
US10077470B2 (en) | 2015-07-21 | 2018-09-18 | Omniome, Inc. | Nucleic acid sequencing methods and systems |
ES2864677T3 (en) * | 2015-07-30 | 2021-10-14 | Illumina Inc | Orthogonal nucleotide unlocking |
WO2017087724A1 (en) | 2015-11-17 | 2017-05-26 | Omniome, Inc. | Methods for determining sequence profiles |
CN109072297B (en) * | 2016-04-22 | 2022-09-13 | 加利福尼亚太平洋生物科学股份有限公司 | Nucleic acid sequencing methods and systems using enhanced nucleotide-specific ternary complex formation detection |
US10597643B2 (en) | 2016-04-29 | 2020-03-24 | Omniome, Inc. | Polymerases engineered to reduce nucleotide-independent DNA binding |
CA3022431C (en) | 2016-04-29 | 2023-03-21 | Omniome, Inc. | Method of nucleic acid sequence determination |
US10294514B2 (en) | 2016-04-29 | 2019-05-21 | Omniome, Inc. | Sequencing method employing ternary complex destabilization to identify cognate nucleotides |
WO2018034780A1 (en) * | 2016-08-15 | 2018-02-22 | Omniome, Inc. | Sequencing method for rapid identification and processing of cognate nucleotide pairs |
CN109844136A (en) | 2016-08-15 | 2019-06-04 | 欧姆尼奥姆股份有限公司 | The method and system of sequencing nucleic acid |
WO2018125759A1 (en) | 2016-12-30 | 2018-07-05 | Omniome, Inc. | Method and system employing distinguishable polymerases for detecting ternary complexes and identifying cognate nucleotides |
EP3571319A1 (en) | 2017-01-20 | 2019-11-27 | Omniome, Inc. | Process for cognate nucleotide detection in a nucleic acid sequencing workflow |
WO2018136117A1 (en) | 2017-01-20 | 2018-07-26 | Omniome, Inc. | Allele-specific capture of nucleic acids |
US9932631B1 (en) | 2017-09-11 | 2018-04-03 | Omniome, Inc. | Genotyping by polymerase binding |
US9951385B1 (en) | 2017-04-25 | 2018-04-24 | Omniome, Inc. | Methods and apparatus that increase sequencing-by-binding efficiency |
US10161003B2 (en) | 2017-04-25 | 2018-12-25 | Omniome, Inc. | Methods and apparatus that increase sequencing-by-binding efficiency |
AU2018353136B2 (en) | 2017-10-19 | 2022-05-19 | Pacific Biosciences Of California, Inc. | Simultaneous background reduction and complex stabilization in binding assay workflows |
CN112368397A (en) * | 2018-03-13 | 2021-02-12 | 萨摩尔股份有限公司 | Method for single molecule sequencing |
US11180794B2 (en) | 2018-05-31 | 2021-11-23 | Omniome, Inc. | Methods and compositions for capping nucleic acids |
AU2019276719A1 (en) | 2018-05-31 | 2020-11-26 | Pacific Biosciences Of California, Inc. | Increased signal to noise in nucleic acid sequencing |
EP3608422A1 (en) | 2018-08-08 | 2020-02-12 | Amaryllis Innovation GmbH | Electrochemical detection of polymerase reactions by specific metal-phosphate complex formation |
US10768173B1 (en) | 2019-09-06 | 2020-09-08 | Element Biosciences, Inc. | Multivalent binding composition for nucleic acid analysis |
US10876148B2 (en) | 2018-11-14 | 2020-12-29 | Element Biosciences, Inc. | De novo surface preparation and uses thereof |
US10704094B1 (en) | 2018-11-14 | 2020-07-07 | Element Biosciences, Inc. | Multipart reagents having increased avidity for polymerase binding |
CN117680210A (en) | 2018-12-07 | 2024-03-12 | 元素生物科学公司 | Flow cell device, cartridge and system |
US11287422B2 (en) | 2019-09-23 | 2022-03-29 | Element Biosciences, Inc. | Multivalent binding composition for nucleic acid analysis |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005003375A2 (en) * | 2003-01-29 | 2005-01-13 | 454 Corporation | Methods of amplifying and sequencing nucleic acids |
WO2005123957A2 (en) * | 2004-06-10 | 2005-12-29 | Ge Healthcare Bio-Sciences Corp. | Method for nucleic acid analysis |
US20060051807A1 (en) * | 2004-06-10 | 2006-03-09 | Fuller Carl W | Rapid parallel nucleic acid analysis |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4971903A (en) * | 1988-03-25 | 1990-11-20 | Edward Hyman | Pyrophosphate-based method and apparatus for sequencing nucleic acids |
US5516633A (en) * | 1991-08-15 | 1996-05-14 | Amersham Life Science, Inc. | DNA sequencing with a T7-type gene 6 exonuclease |
US5674679A (en) | 1991-09-27 | 1997-10-07 | Amersham Life Science, Inc. | DNA cycle sequencing |
US5432065A (en) * | 1993-03-30 | 1995-07-11 | United States Biochemical Corporation | Cycle sequencing with non-thermostable DNA polymerases |
US20030108867A1 (en) * | 1999-04-20 | 2003-06-12 | Chee Mark S | Nucleic acid sequencing using microsphere arrays |
WO2001073121A1 (en) * | 2000-03-30 | 2001-10-04 | Toyota Jidosha Kabushiki Kaisha | Method of determining base sequence of single nucleic acid molecule |
GB0103622D0 (en) * | 2001-02-14 | 2001-03-28 | Univ Cambridge Tech | Methods for detecting DNA polymerisation |
WO2002072892A1 (en) * | 2001-03-12 | 2002-09-19 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |
-
2005
- 2005-10-21 US US11/255,683 patent/US7264934B2/en active Active
-
2006
- 2006-10-20 JP JP2008536859A patent/JP5160433B2/en active Active
- 2006-10-20 EP EP06826449.8A patent/EP1954827B1/en active Active
- 2006-10-20 WO PCT/US2006/041232 patent/WO2007048033A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005003375A2 (en) * | 2003-01-29 | 2005-01-13 | 454 Corporation | Methods of amplifying and sequencing nucleic acids |
WO2005123957A2 (en) * | 2004-06-10 | 2005-12-29 | Ge Healthcare Bio-Sciences Corp. | Method for nucleic acid analysis |
US20060051807A1 (en) * | 2004-06-10 | 2006-03-09 | Fuller Carl W | Rapid parallel nucleic acid analysis |
Non-Patent Citations (1)
Title |
---|
See also references of WO2007048033A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007048033A1 (en) | 2007-04-26 |
US20060051807A1 (en) | 2006-03-09 |
EP1954827B1 (en) | 2013-07-24 |
US7264934B2 (en) | 2007-09-04 |
EP1954827A4 (en) | 2009-12-09 |
JP2009512452A (en) | 2009-03-26 |
JP5160433B2 (en) | 2013-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7264934B2 (en) | Rapid parallel nucleic acid analysis | |
AU2005254984B2 (en) | Method for nucleic acid analysis | |
US10590479B2 (en) | Polymerase idling method for single molecule DNA sequencing | |
US8795961B2 (en) | Preparations, compositions, and methods for nucleic acid sequencing | |
US20090163366A1 (en) | Two-primer sequencing for high-throughput expression analysis | |
EP3146075B1 (en) | Ion sensor dna and rna sequencing by synthesis using nucleotide reversible terminators | |
IL297992B1 (en) | Nucleosides and nucleotides with 3' acetal blocking group | |
WO2004092331A2 (en) | Composition and method for nucleic acid sequencing | |
WO2002044425A2 (en) | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity | |
AU2007342173A1 (en) | Ligation amplification | |
JP2018518947A (en) | Orthogonal deblocking of nucleotides | |
JP2002531106A (en) | Determination of length of nucleic acid repeats by discontinuous primer extension | |
EP4028552A1 (en) | Enhanced optical detection for nucleic acid sequencing using thermally-dependent fluorophore tags | |
KR20230120985A (en) | Methods, systems and compositions for nucleic acid sequencing | |
CA2446310C (en) | Analytical method and kit | |
US20110045485A1 (en) | Analytical method and kit | |
WO2006127420A1 (en) | Methods for improving fidelity in a nucleic acid synthesis reaction | |
WO2009086353A1 (en) | Improved two-primer sequencing for high-throughput expression analysis | |
JP2005537001A (en) | Allele-specific primer extension | |
US20140127698A1 (en) | Reiterative oligonucleotide synthesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080421 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20091105 |
|
17Q | First examination report despatched |
Effective date: 20100112 |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 623518 Country of ref document: AT Kind code of ref document: T Effective date: 20130815 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602006037542 Country of ref document: DE Effective date: 20130919 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 623518 Country of ref document: AT Kind code of ref document: T Effective date: 20130724 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20130724 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130626 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131125 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131124 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131025 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20140425 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131031 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131031 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602006037542 Country of ref document: DE Effective date: 20140425 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131020 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20061020 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131020 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602006037542 Country of ref document: DE Owner name: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC, MARLBO, US Free format text: FORMER OWNER: GE HEALTHCARE BIO-SCIENCES CORP., PISCATAWAY, N.J., US |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230526 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240829 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240821 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240828 Year of fee payment: 19 |